Haemonetics Aktie

Haemonetics für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 881782 / ISIN: US4050241003

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
30.09.2013 14:00:00

Haemonetics Sets Date for Second Quarter Fiscal Year 2014 Earnings Release: October 28, 2013

BRAINTREE, Mass., Sept. 30, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the second quarter of its fiscal year 2014on October 28, 2013 in a pre-market press release.  The Company will host a conference call which will be webcast, to discuss and answer questions about the press release at 8:00 am Eastern on October 28, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )

Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=5029732

Webcast replay will be available from October 28, 2013 after 11:00 am (EDT) until November 4, 2013.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
gerry.gould@haemonetics.com
Alt. (781) 356-9613

SOURCE Haemonetics Corporation

Analysen zu Haemonetics Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Haemonetics Corp. 51,00 -1,92% Haemonetics Corp.